SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

Communiqués Shanghai Pharmaceuticals Holding Co., Ltd

Actions

601607

CNE000000C82

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
18,78 ^CNY	+1,84 %		+3,41 %	+12,25 %

27/05	Shanghai Pharmaceuticals Holding Co. annonce la démission de Chen Fashu en tant qu'administrateur non exécutif	CI
27/05	Shanghai Pharma obtient l'approbation des essais cliniques pour ses antidépresseurs	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shionogi & Co., Ltd. - Notice Regarding a License Agreement for Promotion of Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19, in China	30/12/22	AQ
Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE EXTRAORDINARY GENERAL MEETING	26/07/21	PU
Shanghai Pharmaceuticals : The Fortune 500 company Shanghai Pharmaceuticals enters the dental equipment market by acquiring Finnish dental equipment company Fimet Oy and its operations in Finland and China	06/07/21	AQ
Shanghai Pharmaceuticals : CONNECTED TRANSACTION PROPOSED NON-PUBLIC ISSUANCE OF A SHARES	12/05/21	PU
Shanghai Pharmaceuticals : SUPPLEMENT ANNOUNCEMENT TO THE 2019 SHARE OPTION INCENTIVE SCHEME OF THE COMPANY	21/08/20	PU
Enzymatica publ : signs agreement with Keyuan Trade for China	22/01/20	AQ
Shanghai Pharmaceuticals : GRANT OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME	19/12/19	PU
Shanghai Pharmaceuticals : RESULTS OF THE EXTRAORDINARY GENERAL MEETING, A SHARE CLASS MEETING, AND H SHARE CLASS MEETING	18/12/19	PU
Shanghai Pharmaceuticals : Notification Letter and Change Request Form to Registered Shareholder	31/10/19	PU
Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE 2019 SECOND H SHARE CLASS MEETING	31/10/19	PU
Shanghai Pharmaceuticals : FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2019 SECOND H SHARE CLASS MEETING	31/10/19	PU
Shanghai Pharmaceuticals : PROXY FORM OF THE INDEPENDENT NON-EXECUTIVE DIRECTOR FOR USE AT THE 2019 SECOND H SHARE CLASS MEETING	31/10/19	PU
Shanghai Pharmaceuticals : NOTICE OF 2019 SECOND H SHARE CLASS MEETING	31/10/19	PU
Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE 2019 FIRST EXTRAORDINARY GENERAL MEETING	31/10/19	PU
Shanghai Pharmaceuticals : PROXY FORM OF HOLDERS OF H SHARES FOR USE AT THE 2019 FIRST EXTRAORDINARY GENERAL MEETING	31/10/19	PU
Shanghai Pharmaceuticals : PROXY FORM OF THE INDEPENDENT NON-EXECUTIVE DIRECTOR FOR USE AT THE 2019 FIRST EXTRAORDINARY GENERAL MEETING	31/10/19	PU
Shanghai Pharmaceuticals : Proposed Adoption of the 2019 Share Option Scheme Assessment Management Measures for the Implementation of the 2019 Share Option Scheme and Proposed Authorization to the Board to Deal with Relevant Matters in Relation to the 2019 Share Option Scheme	31/10/19	PU
Shanghai Pharmaceuticals : PROPOSED ADOPTION OF THE SHARE OPTION SCHEME AND THE GRANT THEREUNDER	30/09/19	PU
Shanghai Pharmaceuticals : CSRC'S APPROVAL ON ISSUANCE OF NEW H SHARES	20/09/19	PU
Shanghai Pharmaceuticals : Notification Letter and Change Request Form to Registered Shareholder	16/09/19	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Shanghai Pharmaceuticals Holding Co., Ltd

Actions

601607

CNE000000C82

Communiqués

Filtres